Preparations for treatment and prevention of loss of bone structure by natural tooth and/or implant.
Periodontitis effects over 50% of adult population whereas peri-implant mucositis and peri-implantitis effect 80% and 28-35% implants. We approach these indications as chronic disorders and therefore seek for long-term sustainable results providing patient with maximal effectiveness of the treatment and long-term minimal costs.
The bone protection products are the innovation of effectively combatting -hard and soft tissue- destructive biofilm: both chemically and mechanically. Intelligent and potent new generation piperacillin/tazobactam antibiotic has been reinforced with regenerative actives and components for different clinical situations. Those regenerative actives and components are needed for implant decontamination and restorative procedures.